⌘K

Home/Filings/4/0001127602-25-008420

4//SEC Filing

Bradway Robert A 4

Accession 0001127602-25-008420

CIK 0000318154other

View on SEC.gov Company Profile

Filed

Mar 4, 7:00 PM ET

Accepted

Mar 5, 7:55 PM ET

Size

6.3 KB

Accession

0001127602-25-008420

Insider Transaction Report

Form 4

Period: 2025-03-03

Bradway Robert A

Executive V.P. and CFO

Transactions

Award
Common Stock
2025-03-03+25,734→ 599,925 total

Holdings

Common Stock
(indirect: By GRAT)
90,000
Common Stock
(indirect: By Spousal GRAT)
90,000

Footnotes (1)

[F1]These shares include 2,477 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.

Documents

1 file

4
form4.xmlPrimary
PRIMARY DOCUMENT

Issuer

AMGEN INC

CIK 0000318154

Entity typeother

Related Parties

1

filerCIK 0001396482

Filing Metadata

Form type: 4
Filed: Mar 4, 7:00 PM ET
Accepted: Mar 5, 7:55 PM ET
Size: 6.3 KB

View on SEC.gov